Longitudinal proteomic analysis of severe COVID-19 reveals survival-associated signatures, tissue-specific cell death, and cell-cell interactions

Michael R. Filbin(Harvard University), Arnav Mehta(Dana-Farber Cancer Institute), Alexis M. Schneider(Massachusetts Institute of Technology), Kyle R. Kays(Massachusetts General Hospital), Jamey Guess(Olink (United States)), Matteo Gentili(Massachusetts Institute of Technology), Bánk G. Fenyves(Semmelweis University), Nicole C. Charland(Massachusetts General Hospital), Anna Gonye(Massachusetts Institute of Technology), Irena Gushterova(Broad Institute), Hargun K. Khanna(Massachusetts General Hospital), Thomas J. LaSalle(Massachusetts Institute of Technology), Kendall M. Lavin-Parsons(Massachusetts General Hospital), Brendan M. Lilley(Massachusetts General Hospital), Carl L. Lodenstein(Massachusetts General Hospital), Kasidet Manakongtreecheep(Massachusetts Institute of Technology), Justin Margolin(Massachusetts General Hospital), Brenna McKaig(Massachusetts General Hospital), Maricarmen Rojas-López(Harvard University), Brian C. Russo(Massachusetts General Hospital), Nihaarika Sharma(Center for Cancer Research), Jessica Tantivit(Broad Institute), Molly Thomas(Center for Cancer Research), Robert E. Gerszten(Beth Israel Deaconess Medical Center), Graham Heimberg(Broad Institute), Paul Hoover(Brigham and Women's Hospital), David Lieb(Broad Institute), Brian Lin(Harvard University), Debby Ngo(Beth Israel Deaconess Medical Center), Karin Pelka(Broad Institute), Miguel Reyes(Broad Institute), Christopher S. Smillie(Massachusetts Institute of Technology), Avinash Waghray(Massachusetts General Hospital), Thomas E. Wood(Massachusetts General Hospital), Amanda S. Zajac(Harvard University), Lori L. Jennings(Novartis (United States)), Ida Grundberg(Olink (United States)), Roby P. Bhattacharyya(Massachusetts General Hospital), Blair A. Parry(Massachusetts General Hospital), Alexandra–Chloé Villani(Harvard University), Moshe Sade-Feldman(Broad Institute), Nir Hacohen(Harvard University), Marcia B. Goldberg(Massachusetts General Hospital)
Cell Reports Medicine
May 1, 2021
Cited by 309Open Access
Full Text

Abstract

Mechanisms underlying severe coronavirus disease 2019 (COVID-19) disease remain poorly understood. We analyze several thousand plasma proteins longitudinally in 306 COVID-19 patients and 78 symptomatic controls, uncovering immune and non-immune proteins linked to COVID-19. Deconvolution of our plasma proteome data using published scRNA-seq datasets reveals contributions from circulating immune and tissue cells. Sixteen percent of patients display reduced inflammation yet comparably poor outcomes. Comparison of patients who died to severely ill survivors identifies dynamic immune-cell-derived and tissue-associated proteins associated with survival, including exocrine pancreatic proteases. Using derived tissue-specific and cell-type-specific intracellular death signatures, cellular angiotensin-converting enzyme 2 (ACE2) expression, and our data, we infer whether organ damage resulted from direct or indirect effects of infection. We propose a model in which interactions among myeloid, epithelial, and T cells drive tissue damage. These datasets provide important insights and a rich resource for analysis of mechanisms of severe COVID-19 disease.


Related Papers

No related papers found

Powered by citation graph analysis